Aurobindo gets FDA approval for lacosamide oral solution
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application lacosamide oral solution USP, 10mg/mLs.